Breakdown | |||||
TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.73B | 2.74B | 2.77B | 2.59B | 2.43B | 1.95B | Gross Profit |
1.03B | 1.04B | 1.02B | 885.53M | 837.98M | 682.47M | EBIT |
451.42M | 447.45M | 404.17M | 329.06M | 306.21M | 202.13M | EBITDA |
480.89M | 502.08M | 465.14M | 418.14M | 393.69M | 299.25M | Net Income Common Stockholders |
272.25M | 264.84M | 203.73M | 223.75M | 235.11M | 157.41M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
76.50M | 249.36M | 102.00M | 72.02M | 41.21M | 49.21M | Total Assets |
3.83B | 4.03B | 3.83B | 3.75B | 3.46B | 3.39B | Total Debt |
1.09B | 1.16B | 1.12B | 1.24B | 109.24M | 97.04M | Net Debt |
1.01B | 913.88M | 1.02B | 1.17B | 68.03M | 47.83M | Total Liabilities |
2.15B | 2.23B | 2.18B | 2.37B | 959.53M | 841.06M | Stockholders Equity |
1.64B | 1.77B | 1.61B | 1.35B | 2.46B | 2.50B |
Cash Flow | Free Cash Flow | ||||
294.68M | 303.62M | 282.32M | 174.12M | 215.15M | 269.04M | Operating Cash Flow |
346.34M | 355.40M | 330.49M | 214.36M | 250.74M | 309.18M | Investing Cash Flow |
-181.77M | -205.70M | -62.24M | -184.42M | -35.27M | -34.57M | Financing Cash Flow |
52.47M | 31.67M | -219.72M | 7.56M | -221.57M | -326.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $11.46B | 32.61 | 21.78% | 0.35% | 7.40% | 168.67% | |
77 Outperform | $7.47B | 27.67 | 16.64% | 0.26% | -1.85% | 16.06% | |
76 Outperform | $10.67B | 27.37 | 25.42% | ― | 6.82% | 3.49% | |
74 Outperform | $8.39B | 13.82 | 24.51% | 1.12% | 18.81% | 10.05% | |
70 Outperform | $2.66B | 49.80 | 13.01% | 0.76% | 2.61% | -53.74% | |
66 Neutral | $2.87B | 48.16 | 6.56% | 1.16% | -69.82% | -78.10% | |
64 Neutral | $4.39B | 11.81 | 5.20% | 249.39% | 3.96% | -12.36% |
At the 2025 Annual Meeting on May 8, ESAB Corporation‘s stockholders approved the Amended and Restated 2022 Omnibus Incentive Plan, which includes several updates such as enabling consultants to receive grants, increasing the annual limit for non-employee directors, and extending the plan’s termination date. Additionally, the meeting saw the election of four Class III directors, the ratification of Ernst & Young LLP as the accounting firm, and the approval of executive compensation, indicating strong shareholder support for the company’s strategic decisions.
The most recent analyst rating on (ESAB) stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on ESAB Corporation stock, see the ESAB Stock Forecast page.